Tinca, A.C.; Cocuz, I.G.; Șincu, M.C.; Niculescu, R.; Sabău, A.H.; Chiorean, D.M.; Szőke, A.R.; Cotoi, O.S.
VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma. Medicina 2022, 58, 74.
https://doi.org/10.3390/medicina58010074
AMA Style
Tinca AC, Cocuz IG, Șincu MC, Niculescu R, Sabău AH, Chiorean DM, Szőke AR, Cotoi OS.
VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma. Medicina. 2022; 58(1):74.
https://doi.org/10.3390/medicina58010074
Chicago/Turabian Style
Tinca, Andreea Cătălina, Iuliu Gabriel Cocuz, Mihaela Cornelia Șincu, Raluca Niculescu, Adrian Horațiu Sabău, Diana Maria Chiorean, Andreea Raluca Szőke, and Ovidiu Simion Cotoi.
2022. "VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma" Medicina 58, no. 1: 74.
https://doi.org/10.3390/medicina58010074
APA Style
Tinca, A. C., Cocuz, I. G., Șincu, M. C., Niculescu, R., Sabău, A. H., Chiorean, D. M., Szőke, A. R., & Cotoi, O. S.
(2022). VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma. Medicina, 58(1), 74.
https://doi.org/10.3390/medicina58010074
